novel egfr inhibitor combinations for nsclc
Published 5 years ago • 169 plays • Length 3:35Download video MP4
Download video MP3
Similar videos
-
3:29
pre-clinical data for novel egfr inhibitor bdtx-1535
-
6:46
selecting a first-line egfr inhibitor in nsclc
-
26:27
novel egfr inhibitors in the setting of acquired resistance
-
0:59
dr. padda on novel combinations for egfr nsclc
-
16:22
novel combinations in egfr positive advanced nsclc
-
37:23
nsclc: integrating egfr-inhibiting therapies into clinical pathways for first-line treatment
-
10:30
tumor clonality in egfr mutation-positive nsclc
-
28:17
segment 1: egfr tkis in nsclc
-
2:37
promising treatment combinations in egfr nsclc
-
2:27
combining egfr and vegf inhibitors for nsclc
-
7:00
novel immunotherapy combinations in nsclc
-
7:51
nsclc: egfr inhibition and resistance mechanisms
-
8:07
novel trials of immunotherapy combinations for nsclc
-
2:20
new target for treatment resistance after egfr inhibitors found in lung cancer study
-
6:37
novel egfr exon 20 directed therapies for nsclc
-
2:20
novel immunotherapy combinations for nsclc
-
3:41
egfr inhibitors as adjuvant therapy in nsclc
-
4:28
overcoming resistance to egfr inhibitors in nsclc
-
6:39
tki combinations in metastatic egfr lung cancer
-
8:16
immune checkpoint inhibitor combinations in non-small cell lung cancer
-
1:05
dr. ramalingam on the activity of osimertinib combinations in nsclc
-
5:32
introduction to egfr inhibitors